Abstract
Use of zolpidem, a short-acting imidazopyridine hypnotic, has not been associated with teratogenic effects in usual clinical doses. We report a case of fetal neural tube defects occurring in a female dependent on zolpidem and consuming high doses in the first trimester of pregnancy. Possible mechanisms by which high dose zolpidem may lead to teratogenicity are discussed. Clinicians are advised to be aware of the risks of high-dose zolpidem abuse in early pregnancy.
Keywords: Neural tube defects, zolpidem, high dose, teratogenicity, meningo-myelocele
Current Drug Safety
Title: High Dose Zolpidem Induced Fetal Neural Tube Defects
Volume: 6 Issue: 2
Author(s): Avinash Sharma, Neha Sayeed, Christoday R.J. Khess and Sayeed Akhtar
Affiliation:
Keywords: Neural tube defects, zolpidem, high dose, teratogenicity, meningo-myelocele
Abstract: Use of zolpidem, a short-acting imidazopyridine hypnotic, has not been associated with teratogenic effects in usual clinical doses. We report a case of fetal neural tube defects occurring in a female dependent on zolpidem and consuming high doses in the first trimester of pregnancy. Possible mechanisms by which high dose zolpidem may lead to teratogenicity are discussed. Clinicians are advised to be aware of the risks of high-dose zolpidem abuse in early pregnancy.
Export Options
About this article
Cite this article as:
Sharma Avinash, Sayeed Neha, R.J. Khess Christoday and Akhtar Sayeed, High Dose Zolpidem Induced Fetal Neural Tube Defects, Current Drug Safety 2011; 6 (2) . https://dx.doi.org/10.2174/157488611795684695
DOI https://dx.doi.org/10.2174/157488611795684695 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
3D Printing Technology in Pharmaceutical Manufacturing and Drug Delivery Application
Current Pharmaceutical Design Non-Antidepressant Treatment of Generalized Anxiety Disorder
Current Clinical Pharmacology Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and LDopa Treatment
Current Genomics Neuroactive Steroids as Endogenous Modulators of Anxiety
Current Pharmaceutical Design Curcumin Activates Erythrocyte Membrane Acetylcholinesterase
Letters in Drug Design & Discovery Computational Study and Synthesis of a New Class of Anticonvulsants with 6 Hz Psychomotor Seizure Test Activity: 2-(1,3-benzodioxol-5-yloxy)- N'-[substituted]-acetohydrazides
Medicinal Chemistry Synthesis and Structure-Activity Relationships of 4,10-Dihydro-4-oxo-4HImidazo[ 1,2-a]Indeno[1,2-e]Pyrazine Derivatives: Highly Potent and Selective AMPA Receptor Antagonists with In Vivo Activity
Mini-Reviews in Medicinal Chemistry Gene Therapy as a Novel Pharmaceutical Intervention for Stroke
Current Pharmaceutical Design Progress and Outlooks in a Genetic Absence Epilepsy Model (WAG/Rij)
Current Medicinal Chemistry TRPC Channels and their Implications for Neurological Diseases
CNS & Neurological Disorders - Drug Targets Template Dependent Human DNA Polymerases
Current Topics in Medicinal Chemistry Insight into the Mechanism of the Four-Plate Test-Retest Procedure Using Etifoxine as Compared with Gabapentin
Current Psychopharmacology Inhibition of Monoamine Neurotransmitter Transporters andCentral Nervous System Stimulation Induced by Synthetic Local Anesthetics and Cocaine: A Comparative Review
Current Medicinal Chemistry - Central Nervous System Agents PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and Strategies
Current Pharmaceutical Design Brain Magnetic Stimulation in Animal Models: A Valuable Lesson for Clinical Applications
CNS & Neurological Disorders - Drug Targets α-Substituted Lactams and Acetamides: Ion Channel Modulators that Show Promise in Treating Drug-resistant Epilepsy
Central Nervous System Agents in Medicinal Chemistry Lack of Data on Depression-like States and Antidepressant Pharmacotherapy in Patients with Epilepsy: Randomised Controlled Trials are Badly Needed
Current Pharmaceutical Design Phenolic Acids Exert Anticholinesterase and Cognition-Improving Effects
Current Alzheimer Research An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy
Current Drug Metabolism